trending Market Intelligence /marketintelligence/en/news-insights/trending/ohsxxxdosp4xlyljqa7waw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Cell MedX appoints board member to add medical device experience

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Cell MedX appoints board member to add medical device experience

Carson City, Nev.-based Cell MedX Corp. added George Adams to its board of directors.

Adams was previously CEO of Amorfix Life Sciences, which is known as ProMIS Neurosciences Inc.

The healthcare equipment company said Adams is experienced in bringing medical devices to global markets. Cell MedX develops medical devices for high blood pressure, diabetes and Parkinson's disease.